A phase II, randomized, double-blind, placebo-controlled, dose-ranging study of belimumab in patients with active systemic lupus erythematosus (Q37378350)
Jump to navigation
Jump to search
scientific article published on September 2009
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A phase II, randomized, double-blind, placebo-controlled, dose-ranging study of belimumab in patients with active systemic lupus erythematosus |
scientific article published on September 2009 |
Statements
1 reference
A phase II, randomized, double-blind, placebo-controlled, dose-ranging study of belimumab in patients with active systemic lupus erythematosus (English)
1 reference
Michelle A Petri
1 reference
Joan T Merrill
1 reference
Ellen M Ginzler
1 reference
Daniel J Wallace
1 reference
William Stohl
1 reference
Richard A Furie
1 reference
Jeffrey R Lisse
1 reference
James D McKay
1 reference
W Winn Chatham
1 reference
W Joseph McCune
1 reference
Vivian Fernandez
1 reference
Marc R Chevrier
1 reference
Z John Zhong
1 reference
William W Freimuth
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference